Wyeth profit rises on demand for drugs
240983
Wyeth  on Thursday said its  second-quarter earnings rose on higher sales of its  prescription drugs.
540408
Fourth-quarter profit surged from a year-ago period that included hefty restructuring costs and liability charges related to the companyâs top-selling drug, Zyprexa.
335428
Wyeth WYE.N on Monday reported a  fourth-quarter loss despite strong sales growth of its  prescription medicines, as it took another charge of $4.5  billion for costs related to its recalled fen-phen diet drugs.
80541
NEW YORK, Jan 10  - Wyeth on Monday said it will  support changes in a nationwide legal settlement with users of  its "fen-phen" diet drugs, speeding up compensation to as many  as 40,000 people who say they were harmed by the recalled  medicines.
531085
Drug benefit manager Medco Health Solutions Inc.  on Wednesday reported a higher-than-expected quarterly profit on strong demand for mail-delivered generic medicines and raised its 2007 outlook, sending its shares to an all-time high.
161514
Eli Lilly and Co  on Tuesday said fourth-quarter profit rose on higher-than-expected sales of its medicines, including strong demand for its newer treatments for depression, diabetes and cancer.
748441
The prescription-benefit manager said earnings soared on higher overall revenue and improved results in its specialty pharmacy business.
343050
The drugmaker posted third-quarter net income of $1.53 billion as revenues increased by double digits, while lower costs offset more spending on research and development.
217992
Johnson &amp; Johnson  on Tuesday  said its second-quarter profit rose on higher sales of its  medical devices and prescription medicines.
92996
Wyeth WYE.N on Wednesday reported a  third-quarter profit compared to a year ago, when it took a  large charge for liabilities from its recalled "fen-phen" diet  medicines.
43644
Schering-Plough Corp.  said on Monday that second-quarter earnings rose sharply, fueled by growing demand for its Zetia and Vytorin cholesterol drugs and treatments for arthritis and allergies.
559190
Wyeth on Monday reported a quarterly  loss due to a $4.5 billion charge for its recalled "fen-phen"  diet drugs and warned of disappointing profit for 2005, sending  its shares down almost 8 percent.
6470
Wyeth WYE.N on Wednesday reported a  third-quarter profit, reversing a loss in the year-ago period,  when it took a $2 billion charge for liabilities from its  recalled "fen-phen" diet medicines.
176
Wyeth  on Thursday raised its 2006 profit forecast and said its recently approved Tygacil antibiotic and three experimental medicines all could post annual sales in the billions of dollars.
477244
Pfizer Inc. PFE.N, the world's  biggest drugmaker, on Wednesday said third-quarter earnings  rose on higher sales of key medicines and favorable foreign  exchange factors.
420770
Strong sales of new vaccines and treatments help US drugs group Merck unveil a sharp rise in quarterly profits.
539957
Walgreen Co. WAG.N, the largest U.S.   drugstore chain, posted a 25 percent rise in quarterly profit   on Monday, driven by strong sales of prescription medications   and the addition of the Happy Harry's chain.